EDII Institutional Repository
Method of Monitoring Exposure to Bowman- Birk Inhibitor (BBI) using Monoclonal Antibodies Against Bowman Birk Inhibitor Metabolites
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Gujarat State Biotechnology Mission | |
| dc.date.accessioned | 2019-07-06T09:22:03Z | |
| dc.date.available | 2019-07-06T09:22:03Z | |
| dc.date.issued | 2006 | |
| dc.identifier.uri | http://library.ediindia.ac.in:8181/xmlui//handle/123456789/8918 | |
| dc.language.iso | en | en_US |
| dc.publisher | Gujarat Department of Science and Technology | en_US |
| dc.subject | Bowman-Birk Inhibitor metabolites | en_US |
| dc.subject | cancer chemopreventive agent | en_US |
| dc.subject | Diagnostics | en_US |
| dc.subject | Pharmaceutical and Healthcare | en_US |
| dc.subject | GSBTM | en_US |
| dc.title | Method of Monitoring Exposure to Bowman- Birk Inhibitor (BBI) using Monoclonal Antibodies Against Bowman Birk Inhibitor Metabolites | en_US |
| dc.type | Other | en_US |
